Two commonly used drugs erased the learning and memory deficits caused by fetal alcohol exposure when the drugs were given after birth, according to a new study.
Northwestern Medicine scientists have demonstrated that an enzyme called IDH1 plays a significant role in cancer progression and may be a target for novel drug therapies.
Dane Chetkovich, MD, PhD, professor of Neurology and director of the Medical Scientist Training Program, will be chair of Neurology at Vanderbilt University Medical Center.
Northwestern Medicine scientists found that rhythmic electrical activity called theta oscillations may play an important role in processing scent in the human brain.
An investigational neural stem cell therapy that works with a common cold virus to seek out and attack malignant glioma is being tested at Northwestern Medicine in a phase I clinical trial.
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
A new study shows that a neurodegenerative syndrome in older adults, frontotemporal dementia, shares several fundamental features with another neurodegenerative disease usually seen in children.
Northwestern Medicine scientists have developed a novel testing platform to assess, in real time, the efficacy of nanomaterials in regulating gene expression.
According to a new study, normal agers lost volume in the cortex, which contains neurons, twice as fast as SuperAgers, a rare group of older people whose memories are as sharp as those decades younger.
A new review, published in Nature Reviews Neurology, outlines how upper motor neuron degeneration is an important feature in ALS pathology, and could be key to developing better diagnostic tools and treatments for ALS.